Article Text

FRI0454 Disease Flares and Persistent Low-Level of Disease: Long-Term Outcome in A Cohort of Patients with BehÇEt's Disease
  1. C. Stagnaro1,
  2. R. Talarico1,
  3. C. Ferrari1,
  4. A. d'Ascanio1,
  5. A. Tavoni2,
  6. E. Elefante1,
  7. C. Tani1,
  8. C. Baldini1,
  9. M. Mosca1,
  10. S. Bombardieri1
  1. 1University of Pisa, Rheumatology Unit
  2. 2University of Pisa, Immunoallergology Unit, Pisa, Italy


Background Behçet's disease (BD) is a multisystemic, chronic relapsing inflammatory disease classified among the vasculitis. Neurological and eye involvement are two of the most serious manifestation of BD and both still represent significant causes of morbidity.

Objectives The primary aim of the study was to evaluate the long-term outcome in a cohort of patents with BD; the secondary aim was to explore any potential correlation between long-term outcome and demographic and clinical profile.

Methods The study enrolled 117 patients, all fulfilling the International Study Group (ISG) criteria for BD. One hundred and seventeen patients were retrospectively studied. The male/female ratio was 1.6:1, with a mean disease duration of 11±5 years. Their mean age was 42±9 years (min:18, max:77), while the mean age at disease onset was 25±4 years. The mean ± SD duration of follow-up at our centre was 10±2 years. Long-term outcome was evaluated by means of disease flares according the BD Current Activity Form (BDCAF), persistent low-level of disease (defined as a level minimal activity of disease requiring only low-medium doses of corticosteroids), and disease damage according the Vasculitis Damage Index (VDI). The statistical analysis was performed using Student t-test, Mann-Whitney-U test, ANOVA and Pearson correlation

Results The main clinical features presented during the follow-up by the cohort were: mucocutaneous involvement (100%), joint involvement (49%), ocular involvement (40%), neurological involvement (38%), vascular thrombotic events (22%), gastro-enteric involvement (16%). Globally, we observed 105 episodes of disease flare, of which: 25% of patients with neurological involvement, 60% of ocular involvement, 50% of muco-cutaneous involvement, 12% of joint involvement, 50% of vascular involvement and 28% of gastro-enteric involvement. Thirty-three patients presented a persistent low-level disease, that required a medium corticosteroids dose of 4 mg of 6-methylprednisolone. Moreover, 39 patients presented a VDI >1. A significant correlation was found between disease flares and younger age and male sex; persistent low-level of disease and disease damage resulted significantly associated with early onset of disease and high number of disease flare in the first 2 years of disease. Notably, persistent low-level of disease and disease damage resulted inversely correlated with the use of anti TNF alpha agents, independently of the type of organ involvement.

Conclusions As literature data suggest, a specific demographic profile exists of poor outcome in BD, represented by young males. The use of anti TNF alpha agents is associated with a positive effect on maintaining remission of disease, most likely due to their steroid sparing effect.

Disclosure of Interest None declared

DOI 10.1136/annrheumdis-2014-eular.5696

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.